Diovan HCT 80-12.5 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FU9PQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,201
Award facts
- Contract value 100% obligated
- $8,201.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count) valued at $8,201.10. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated substantial capability in fulfilling military and veteran healthcare pharmaceutical needs through its extensive portfolio of federal contracts. The company serves as a primary supplier for the Defense Logistics Agency's medical supply chain, delivering a comprehensive range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. This delivery order for the antihypertensive medication Diovan HCT exemplifies the company's role in supporting Defense Health Agency and other federal healthcare systems through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FU9PQ?
SPE2DB25FU9PQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FU9PQ worth?
The government has obligated $8,201 on SPE2DB25FU9PQ.
Is contract SPE2DB25FU9PQ an order under another contract?
Yes. SPE2DB25FU9PQ is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9PQ competed?
The extent of competition for SPE2DB25FU9PQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award